After further adjusting for BMI, ALT, AST, AKP, TBIL, UR, and UREA, the OR and 95% CI of participants with HP infection for NAFLD were 1.27 (1.07–1.50) (Model 3). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.